EP3576773
TGF BETA AND ACTRII ANTAGONISTS FOR USE IN TREATING LEUKEMIA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.1.2018EP published:
18.10.2023EP application number:
18747362.4
EPO information:
European Patent Register
Max expiry date:
30.1.2038
Title in English:
TGF BETA AND ACTRII ANTAGONISTS FOR USE IN TREATING LEUKEMIALanguage of the patent:
English
Timeline
Today
31.1.2018EP application
18.10.2023EP Publication
Owner
Name:
Acceleron Pharma Inc.Address:
128 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
PEARSALL, Robert ScottAddress:
North Reading, MA 01864, US
Name:
KUMAR, RavindraAddress:
Acton, MA 01720, US
Priority
Number:
201762453413 PDate:
1.2.2017Country:
US
Classification
Categories:
A61K 38/17, A61K 47/68, A61K 39/395, A61P 35/00, A61P 37/04, A61K 39/00, C07K 14/495, C07K 14/51, C07K 16/22